Finance

Lists
4552:TYO
JCR Pharmaceuticals Co Ltd
483,00 JP¥
+0,42%
(+2,00) 1D
8 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4552...
Open
480 JP¥
High
487 JP¥
Low
471 JP¥
Mkt. cap
64,33 մլրդ
Avg. vol.
612,19 հզր
Volume
974,80 հզր
Dividend
4,14%
Quarterly dividend
5 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
72,04
52-wk high
824 JP¥
52-wk low
444 JP¥
EPS
7 JP¥
Shares outstanding
30,79 մլն
No. of employees
985
Open
480 JP¥
High
487 JP¥
Low
471 JP¥
Mkt. cap
64,33 մլրդ
Avg. vol.
612,19 հզր
Volume
974,80 հզր
Dividend
4,14%
Quarterly dividend
5 JP¥
Ex-dividend date
29 սեպ, 2026 թ.
P/E ratio
72,04
52-wk high
824 JP¥
52-wk low
444 JP¥
EPS
7 JP¥
Shares outstanding
30,79 մլն
No. of employees
985
News stories
From web sources and news partners
Bloomberg Government News
Bloomberg Government News
·
53 րոպե առաջ
Nasdaq-Listed Lobbying Firm Launches Capitol Hill Oversight Unit
www.marketscreener.com
www.marketscreener.com
·
54 րոպե առաջ
Kyivstar to Report 3Q26 Results on November 6, 2026
Yahoo Finance
Yahoo Finance
·
1 ժամ առաջ
Prediction: The S&P 500 Will Hit 10,000 in 2027
About JCR Pharmaceuticals Co Ltd
CEO-
Employees985
Founded13 սեպ, 1975 թ.
Headquarters-
Sector-
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
12,79 մլրդ
8,99 մլրդ
9,97 մլրդ
9,70 մլրդ
Cost of goods sold
1,92 մլրդ
2,39 մլրդ
3,42 մլրդ
2,25 մլրդ
Cost of revenue
1,92 մլրդ
2,39 մլրդ
3,42 մլրդ
2,25 մլրդ
Research and development expenses
-
-
16,76 մլրդ
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,84 մլրդ
8,50 մլրդ
-10,29 մլրդ
9,55 մլրդ
Operating expense
7,88 մլրդ
8,54 մլրդ
6,48 մլրդ
9,55 մլրդ
Total operating expenses
9,80 մլրդ
10,93 մլրդ
9,90 մլրդ
11,80 մլրդ
Operating income
3,00 մլրդ
-1,94 մլրդ
66,00 մլն
-2,10 մլրդ
Other non operating income
34,00 մլն
49,00 մլն
-65,00 մլն
135,00 մլն
EBT including unusual items
3,34 մլրդ
281,00 մլն
402,00 մլն
-2,08 մլրդ
EBT excluding unusual items
3,12 մլրդ
-1,64 մլրդ
28,00 մլն
-2,08 մլրդ
Income tax expense
1,03 մլրդ
157,00 մլն
27,00 մլն
-166,00 մլն
Effective tax rate
30,79%
55,87%
6,72%
7,97%
Other operating expenses
-
-
-
-
Net income
2,29 մլրդ
69,00 մլն
399,00 մլն
-1,91 մլրդ
Net profit margin
17,92%
0,77%
4,00%
-19,66%
Earnings per share
-
-
-
-
Interest and investment income
30,00 մլն
33,00 մլն
27,00 մլն
23,00 մլն
Interest expense
-78,00 մլն
-151,00 մլն
-90,00 մլն
-157,00 մլն
Net interest expenses
-48,00 մլն
-118,00 մլն
-63,00 մլն
-134,00 մլն
Depreciation and amortization charges
39,00 մլն
36,00 մլն
12,00 մլն
-
EBITDA
3,73 մլրդ
-1,09 մլրդ
705,25 մլն
-1,46 մլրդ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google Apps